De Sèze J - Search Results

1

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups. Barbin L, et al. Among authors: de seze j. Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29. Neurology. 2016. PMID: 26826205 Free PMC article.

2

Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.

de Seze J, Edan G, Labalette M, Dessaint JP, Vermersch P. de Seze J, et al. Ann Neurol. 2000 May;47(5):686. Ann Neurol. 2000. PMID: 10805349 Clinical Trial. No abstract available.

3

Paroxysmal kinesigenic choreoathetosis as a presenting symptom of multiple sclerosis.

de Seze J, Stojkovic T, Destée M, Destée A, Vermersch P. de Seze J, et al. J Neurol. 2000 Jun;247(6):478-80. doi: 10.1007/s004150070184. J Neurol. 2000. PMID: 10929284 Review. No abstract available.

4

Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions.

Stojkovic T, de Seze J, Maurage CA, Rose C, Hache JC, Vermersch P. Stojkovic T, et al. Among authors: de seze j. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):675-8. doi: 10.1136/jnnp.69.5.675. J Neurol Neurosurg Psychiatry. 2000. PMID: 11032628 Free PMC article.

5

Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates.

de Seze J, Stojkovic T, Gauvrit JY, Devos D, Ayachi M, Cassim F, Saint Michel T, Pruvo JP, Guieu JD, Vermersch P. de Seze J, et al. J Neurol. 2001 Apr;248(4):297-303. doi: 10.1007/s004150170204. J Neurol. 2001. PMID: 11374094

6

Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases.

de Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, Hachulla E, Mounier-Vehier F, Pruvo JP, Leys D, Destée A, Hatron PY, Vermersch P. de Seze J, et al. Brain. 2001 Aug;124(Pt 8):1509-21. doi: 10.1093/brain/124.8.1509. Brain. 2001. PMID: 11459743

7

Long-term follow-up of neurosarcoidosis.

Ferriby D, de Seze J, Stojkovic T, Hachulla E, Wallaert B, Destée A, Hatron PY, Vermersch P. Ferriby D, et al. Among authors: de seze j. Neurology. 2001 Sep 11;57(5):927-9. doi: 10.1212/wnl.57.5.927. Neurology. 2001. PMID: 11552036

8

The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis.

de Seze J, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T, Ferriby D, Vermersch P. de Seze J, et al. Neurology. 2001 Oct 23;57(8):1359-63. doi: 10.1212/wnl.57.8.1359. Neurology. 2001. PMID: 11673571

9

[Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].

De Seze J, Mackowiak A, Stojkovic T, Ferriby D, Hautecoeur P, Vermersch P. De Seze J, et al. Rev Neurol (Paris). 2002 Mar;158(3):341-5. Rev Neurol (Paris). 2002. PMID: 11976594 French.

10

Interferon beta1a (Avonex) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability.

Vermersch P, de Seze J, Stojkovic T, Hautecoeur P; G-SEP (Groupe Septentrional d'Etudes et de Recherches sur la SEP). Vermersch P, et al. Among authors: de seze j. J Neurol. 2002 Feb;249(2):184-7. doi: 10.1007/pl00007862. J Neurol. 2002. PMID: 11985384 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters